How to enter
- Register an account.
- Start your entry (save it in-progress).
- Submit your entry to be in the running.
Best of luck!
Start your entryThe NHS increasingly works with medicines companies to deliver improved services to patients. Partnerships between trusts and the industry are varied and represent a range of projects, from access and treatment pathways to service and capacity improvements. As the NHS shifts care closer to home and works to embed prevention and medicines optimisation across the system, these partnerships have a growing role in supporting national priorities.
The judges will be looking for innovative projects which demonstrate best practice and deliver benefits which would have been impossible for the NHS to do by itself. They are likely to deal with a specific patient group and could include audit and data analysis, care co-ordination and new pathways for patients. As well as helping the NHS provide better services within financial constraints, they should offer ongoing benefits after any initial set up period. Crucially, they must add value and not just replicate something the NHS could do for itself.
This award is for partnerships led by a medicines company where the deliverable is about getting the right medicine to the right patient, such as prescribing optimisation, therapy-area pathway redesign or improving access to treatments, including through biosimilar adoption. Partnerships whose deliverable is a diagnostic, device, test, genomic service or body of evidence should enter the Life Sciences Partnership of the Year.
Eligibility
- Medicines companies, including originator, generic and biosimilar manufacturers, supplying services in partnership with NHS organisations.
- The deliverable should concern medicines, such as prescribing optimisation, therapy-area pathway redesign or improving access to treatments, including through biosimilar adoption
- Single partnership or joint working projects • Any size of project may apply, and judges will be reviewing impact and efficacy.
- Eligible projects should have shown clear results within the last two years up to the awards submission deadline